We are analyzing https://link.springer.com/article/10.1007/s11030-015-9621-3.

Title:
Synthesis and anticancer activity of novel fused pyrimidine hybrids of myrrhanone C, a bicyclic triterpene of Commiphora mukul gum resin | Molecular Diversity
Description:
Abstract Myrrhanone C [8(R)-3-oxo-8-hydroxypolypoda-13E,17E,21-triene], a bicyclic triterpene isolated from the gum resin of Commiphora mukul, has been chemically transformed to synthesize a series of ten novel pyrimidine hybrids in good to excellent yields. The synthesized compounds (2–22) were evaluated for their anticancer potential against a panel of six cancer cell lines, namely A-549 (lung), Hela (cervical), MCF-7 (breast), ACHN (renal), Colo-205 (colon) and B-16 (mouse melanoma) by employing the MTT assay. In general, the synthesized compounds showed significant anticancer activity against all the cancer cell lines tested. Interestingly, the pyrimidine hybrids 18 and 19 showed good activity against the A-549, MCF-7, B-16, Colo-205 and ACHN cancer cell lines with $$\hbox {IC}_{50}$$ IC 50 values between 7.7–37.8 $$\upmu $$ μ M. Most significantly, compounds 19 (IC $$_{50}$$ 50 : 7.7 $$\upmu $$ μ M) and 18 (IC $$_{50}$$ 50 : 9.5 $$\upmu $$ μ M) showed about five- and six-fold enhanced activities, respectively, compared to the parent myrrhanone C (1) against A-549 cell line. Flow cytometric analysis revealed that compounds 18 and 19 induced apoptosis in A-549 cells and arrested the cell growth in the G0/G1 phase. Graphical Abstract
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, google, scholar, cas, pubmed, synthesis, cancer, chem, cell, anticancer, activity, resin, apoptosis, pyrimidine, hybrids, myrrhanone, med, mukul, mallavadhani, lines, privacy, cookies, content, commiphora, gum, ramakrishna, compounds, products, publish, search, fused, bicyclic, triterpene, nayak, activities, access, drug, chemistry, bioorg, derivatives, india, data, information, log, journal, research, molecular, uppuluri, venkata, chandrashekhar,

Topics {✒️}

month download article/chapter uppuluri venkata mallavadhani arrest cell cycle anti-prostate cancer lead structure–activity relationship study full article pdf potential anti-inflammatory interest myrrh-commiphora chemistry medicinal chemistry guggul-gum resin cisplatin-induced apoptosis proceeds cancer cell lines 6-substituted-pyrimidines & 4-styryl-6 privacy choices/manage cookies fold enhanced activities article mallavadhani structure–activity relationship lakshma nayak anti-inflammatory activity anti-cancer activity guggul-gum resins related subjects flow cytometric detection sistla ramakrishna gum resin a-549 cell line potential anticancer agents synthesized 4h-chromene commiphora mukul european economic area g0/g1 phase sung ramaswamy bk octanordammarane-type triterpenes hiv-1 ltr activation situ dna degradation subba rao av ] indolone–pyrrolobenzodiazepine conjugates etoposide-induced apoptosis targeting inflammatory pathways heterocyclic systems fused fused pyrimidine hybrids condensed pyrimidine-thiones conditions privacy policy pharmaceutically valuable compounds 3-oxo-8-hydroxypolypoda-13e breast cancer cells electronic supplementary material anticancer activity article log accepting optional cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Synthesis and anticancer activity of novel fused pyrimidine hybrids of myrrhanone C, a bicyclic triterpene of Commiphora mukul gum resin
         description:Myrrhanone C [8(R)-3-oxo-8-hydroxypolypoda-13E,17E,21-triene], a bicyclic triterpene isolated from the gum resin of Commiphora mukul, has been chemically transformed to synthesize a series of ten novel pyrimidine hybrids in good to excellent yields. The synthesized compounds (2–22) were evaluated for their anticancer potential against a panel of six cancer cell lines, namely A-549 (lung), Hela (cervical), MCF-7 (breast), ACHN (renal), Colo-205 (colon) and B-16 (mouse melanoma) by employing the MTT assay. In general, the synthesized compounds showed significant anticancer activity against all the cancer cell lines tested. Interestingly, the pyrimidine hybrids 18 and 19 showed good activity against the A-549, MCF-7, B-16, Colo-205 and ACHN cancer cell lines with $$\hbox {IC}_{50}$$ values between 7.7–37.8 $$\upmu $$ M. Most significantly, compounds 19 (IC $$_{50}$$ : 7.7 $$\upmu $$ M) and 18 (IC $$_{50}$$ : 9.5 $$\upmu $$ M) showed about five- and six-fold enhanced activities, respectively, compared to the parent myrrhanone C (1) against A-549 cell line. Flow cytometric analysis revealed that compounds 18 and 19 induced apoptosis in A-549 cells and arrested the cell growth in the G0/G1 phase.
         datePublished:2015-08-01T00:00:00Z
         dateModified:2015-08-01T00:00:00Z
         pageStart:745
         pageEnd:757
         sameAs:https://doi.org/10.1007/s11030-015-9621-3
         keywords:
            Myrrhanone C
            Pyrimidines
            Hybrids
            Anticancer activity
            Apoptosis
            Cell cycle arrest
            Biochemistry
            general
            Organic Chemistry
            Polymer Sciences
            Pharmacy
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Figa_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Sch1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig4_HTML.jpg
         isPartOf:
            name:Molecular Diversity
            issn:
               1573-501X
               1381-1991
            volumeNumber:19
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Uppuluri Venkata Mallavadhani
               affiliation:
                     name:CSIR-Indian Institute of Chemical Technology
                     address:
                        name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Madasu Chandrashekhar
               affiliation:
                     name:CSIR-Indian Institute of Chemical Technology
                     address:
                        name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vadithe Lakshma Nayak
               affiliation:
                     name:CSIR-Indian Institute of Chemical Technology
                     address:
                        name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sistla Ramakrishna
               affiliation:
                     name:CSIR-Indian Institute of Chemical Technology
                     address:
                        name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Synthesis and anticancer activity of novel fused pyrimidine hybrids of myrrhanone C, a bicyclic triterpene of Commiphora mukul gum resin
      description:Myrrhanone C [8(R)-3-oxo-8-hydroxypolypoda-13E,17E,21-triene], a bicyclic triterpene isolated from the gum resin of Commiphora mukul, has been chemically transformed to synthesize a series of ten novel pyrimidine hybrids in good to excellent yields. The synthesized compounds (2–22) were evaluated for their anticancer potential against a panel of six cancer cell lines, namely A-549 (lung), Hela (cervical), MCF-7 (breast), ACHN (renal), Colo-205 (colon) and B-16 (mouse melanoma) by employing the MTT assay. In general, the synthesized compounds showed significant anticancer activity against all the cancer cell lines tested. Interestingly, the pyrimidine hybrids 18 and 19 showed good activity against the A-549, MCF-7, B-16, Colo-205 and ACHN cancer cell lines with $$\hbox {IC}_{50}$$ values between 7.7–37.8 $$\upmu $$ M. Most significantly, compounds 19 (IC $$_{50}$$ : 7.7 $$\upmu $$ M) and 18 (IC $$_{50}$$ : 9.5 $$\upmu $$ M) showed about five- and six-fold enhanced activities, respectively, compared to the parent myrrhanone C (1) against A-549 cell line. Flow cytometric analysis revealed that compounds 18 and 19 induced apoptosis in A-549 cells and arrested the cell growth in the G0/G1 phase.
      datePublished:2015-08-01T00:00:00Z
      dateModified:2015-08-01T00:00:00Z
      pageStart:745
      pageEnd:757
      sameAs:https://doi.org/10.1007/s11030-015-9621-3
      keywords:
         Myrrhanone C
         Pyrimidines
         Hybrids
         Anticancer activity
         Apoptosis
         Cell cycle arrest
         Biochemistry
         general
         Organic Chemistry
         Polymer Sciences
         Pharmacy
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Figa_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Sch1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11030-015-9621-3/MediaObjects/11030_2015_9621_Fig4_HTML.jpg
      isPartOf:
         name:Molecular Diversity
         issn:
            1573-501X
            1381-1991
         volumeNumber:19
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Uppuluri Venkata Mallavadhani
            affiliation:
                  name:CSIR-Indian Institute of Chemical Technology
                  address:
                     name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Madasu Chandrashekhar
            affiliation:
                  name:CSIR-Indian Institute of Chemical Technology
                  address:
                     name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vadithe Lakshma Nayak
            affiliation:
                  name:CSIR-Indian Institute of Chemical Technology
                  address:
                     name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sistla Ramakrishna
            affiliation:
                  name:CSIR-Indian Institute of Chemical Technology
                  address:
                     name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular Diversity
      issn:
         1573-501X
         1381-1991
      volumeNumber:19
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:CSIR-Indian Institute of Chemical Technology
      address:
         name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
         type:PostalAddress
      name:CSIR-Indian Institute of Chemical Technology
      address:
         name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
         type:PostalAddress
      name:CSIR-Indian Institute of Chemical Technology
      address:
         name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
         type:PostalAddress
      name:CSIR-Indian Institute of Chemical Technology
      address:
         name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Uppuluri Venkata Mallavadhani
      affiliation:
            name:CSIR-Indian Institute of Chemical Technology
            address:
               name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Madasu Chandrashekhar
      affiliation:
            name:CSIR-Indian Institute of Chemical Technology
            address:
               name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
               type:PostalAddress
            type:Organization
      name:Vadithe Lakshma Nayak
      affiliation:
            name:CSIR-Indian Institute of Chemical Technology
            address:
               name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
               type:PostalAddress
            type:Organization
      name:Sistla Ramakrishna
      affiliation:
            name:CSIR-Indian Institute of Chemical Technology
            address:
               name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
      name:Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
      name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
      name:Department of Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(111)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.71s.

LINK . SPRINGER . COM {}